Please activate JavaScript!
Please install Adobe Flash Player, click here for download

SAfW Wundkompendium

52 · Wund Management Sonderheft 3/2012 Advanced Methods 34. Veves A, Falanga V, Armstrong D, Sabolinski M: Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of nonin- fected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 290–5. 35. Limat A, Mauri D, Hunziker T: Success- ful treatment of chronic leg ulcers with epi- dermal equivalents generated from cultured autologous outer root sheath cells. J Invest Dermatol 1996; 107: 128–35. 36. Tausche A, Skaria M, Böhlen L, et al: An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen 2003 11: 248–52. 37. Ortega-Zilic N, Hunziker T, Läuchli S, et al: EpiDex® Swiss field trial 2004-2008. Dermatology 2010; 221: 365–72. 38. Falanga V, Iwamoto S, Chartier M, et al: Autologous bone marrow-derived cul- tured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007; 13: 1299–312. 39. Vojtassák J, Danisovic L, Kubes M, et al: Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006 27 Suppl 2: 134–7. 40. Eming S, Krieg T, Davidson J: Gene therapy and wound healing. Clin Dermatol 2007; 25: 79–92. 27. von Felbert V, Schumann H, Mercer J, Strasser W, Daeschlein G, Hoffmann G: Therapy of chronic wounds with water- filtered infrared-A (wIRA). GMS Krankenh- hyg Interdiszip 2008; 2: Doc52. 28. Mercer J, Nielsen S, Hoffmann G: Improvement of wound healing by water- filtered infrared-A (wIRA) in patients with chronic venous stasis ulcers of the lower legs including evaluation using infrared thermography. Ger Med Sci 2008;21:Doc11. 29. Mayer D, Dorfmüller C, Lachat M: Die extrakorporale Stoßwellentherapie als neue Methode zur Stimulation der Heilung komplexer Wunden: eine Übersicht. ZfW 2009; 1. 30. Costanzo U, Streit M, Braathen L: Autologous suction blister grafting for chro- nic leg ulcers. J Eur Acad Dermatol Venereol 2008; 22: 7–10. 31. SAfW, SGDV: Zertifizierungsprozess von Ärzten, die zur Anwendung von Hautäquiva- lenten berechtigt sind BAG 2011; 2011. 32. Wilkins L, Watson S, Prosky S, Meu- nier S, Parenteau N: Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng 1994; 43. 33. Falanga V, Margolis D, Alvarez O, et al: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998; 134: 293–300. 20. Kakagia D, Kazakos K, Xarchas K, et al: Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospec- tive randomized trial. J Diabetes Complica- tions 2007; 21: 387–91. 21. Niezgoda J, Van Gils C, Frykberg R, Hodde J: Randomized clinical trial compa- ring OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 2005; 18: 258–66. 22. Romanelli M, Dini V, Bertone M, Bar- banera S, Brilli C: OASIS wound matrix versus Hyaloskin in the treatment of difficu- lt-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 2007; 4: 3–7. 23. Romanelli M, Dini V, Bertone M: Rando- mized comparison of OASIS wound matrix versus moist wound dressing in the treat- ment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care 2010; 23: 34–8. 24. SAfW, SGDV: Richtlinien zum Einsatz von azellulären biologisch aktiven Materialien bei schwer heilenden Wunden. BAG 2011. 25. Hoffmann G: Principles and working mechanisms of water-filtered infrared-A (wIRA) in relation to wound healing. GMS Krankenhhyg Interdiszip 2007; 2: Doc54. 26. Biland L, Barras J: Die wassergefilterte Infrarot-A-Hyperthermie zur Behandlung venöser Ulzera. Hefte Wundbehand 2001; 5: 41.

Seitenübersicht